NCT06864689

Brief Summary

The primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Black Women (BW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a high priority Ending the HIV Epidemic (EHE) jurisdiction.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P75+ for early_phase_1

Timeline
12mo left

Started Sep 2026

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
1.5 years until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2027

29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

February 13, 2025

Last Update Submit

February 11, 2026

Conditions

Keywords

Minoritized populationVideo logsPrEPHealth communicationBehavioral intervention

Outcome Measures

Primary Outcomes (2)

  • Number of participants with increased willingness to access or use PrEP

    To assess whether participation in Project ROLE versus usual care will increase the willingness of Black women to access and/or use PrEP

    baseline and day of enrollment and baseline, 1-month, 3-month, and 6-month

  • Number of healthcare providers increased willingness to prescribe and/or refer PrEP

    To assess whether participation in Project ROLE versus usual care will increase the willingness of healthcare providers to prescribe and/or refer PrEP to Black women

    baseline and day of enrollment and baseline, 1-month, 3-month, and 6-month

Secondary Outcomes (3)

  • Number of Black Women started to use of PrEP

    1- month, 3-months, and 6-months follow-up visits

  • Number of PrEP prescriptions or referrals by healthcare providers

    1- month, 3-months, and 6-months follow-up visits

  • PrEP adherence among those who initiated PrEP

    3-months and 6-months follow-up visits

Study Arms (2)

Intervention

EXPERIMENTAL

Participants will watch a health-informed video-log series and complete a second survey (post-test). The post-test will assess the same variables previously assessed in the pre-test.

Behavioral: Video-log (vlog) series with videos tailored to cisgender Black women or to healthcare providers

Standard of Care

NO INTERVENTION

Participant will receive SOC and complete the post-test.

Interventions

This intervention is a video-log (vlog) series based health communication intervention that will be disseminated through community health centers (CHCs) and social media to increase willingness for and use of PrEP among cisgender Black women and to increase willingness to prescribe and refer PrEP among healthcare providers.

Intervention

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsEligible participants in the category for Black Women (BW) must be a woman.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Selection criteria for participation in pilot RCT. Eligible participants in the category for Black Women (BW) must: 1. be a woman 2. be 18 years of age 3. have been sexually active with a man within the past 6 months 4. be fluent in English 5. have a phone or internet access Eligible participants (i.e. PrEP-eligible BW) must not: 1. be unable to provide informed consent/assent for participation (i.e., have severe cognitive impairment hat would interfere with their ability to consent or understand study procedures) 2. have psychological distress that would prohibit them from participating in the study 3. be unable or unwilling to meet study requirements 4. be ineligible for PrEP 5. received a prescription for PrEP within 12 months6)be unable to fill out the evaluation independently Eligible participants in the HCP category must: 1. be a credentialed HCP in Texas with privileges to prescribe and/or refer PrEP 2. BW must be a part of their patient pool at the clinical setting where they practice clinically 3. be fluent in English 4. have a phone or internet access 5. Live and/or practice medicine within a 60-mile radius of Houston/Harris County Eligible HCP must not: 1. be unable to provide informed consent for participation (e.g. have severe cognitive impairment that would interfere with their ability to consent, or ability to understand study procedures 2. have psychological distress that would prohibit them from participating in the study 3. be unable or unwilling to meet study requirements 4. be unwilling to offer PrEP to BW patients 5. have prescribed or referred PrEP to BW within the last 12 months

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University of Texas Medical Branch, Galveston

Galveston, Texas, 77555, United States

Location

Study Officials

  • Mandy Hill, DrPH,MPH,HIVPCP

    University of Texas Medical Branch, Galveston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mandy Hill, Dr.PH, MPH, HIVPCP

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2025

First Posted

March 7, 2025

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

August 2, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations